Skip to content
Căderea părului

Tratamente Căderea părului

Explorati tratamentele căderea părului disponibile. Toate includ analiza unui medic independent din UE, medicamente originale din farmacii autorizate si livrare expres discreta.

2026-04-12 Tratamente

Interested in Căderea părului?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Hair loss tratamente în Europa

Hair loss — medically referred to as alopecia — affects a significant proportion of the European population. Androgenetic alopecia, commonly known as male or female pattern baldness, is the most prevalent form. It is estimated that approximately 50% of men experience noticeable hair loss by the age of 50, and female pattern hair loss is also more common than widely recognised, affecting an estimated 40% of women by the age of 70.

Androgenetic alopecia is driven primarily by genetic predisposition and the action of dihydrotestosterone (DHT), a potent androgen derived from testosterone via the enzyme 5-alpha reductase. DHT causes miniaturisation of hair follicles, leading to progressively finer and shorter hair until follicles are no longer productive. The pattern of loss differs between males and females: men typically experience recession at the temples and crown, while women more commonly experience diffuse thinning over the top of the scalp.

The psychological impact of hair loss should not be underestimated. Research published in peer-reviewed journals has consistently documented associations between hair loss and reduced self-esteem, anxiety, and in some cases clinical depression. The availability of effective pharmacological treatments has improved significantly over recent decades, offering meaningful benefit for many patients when treatment is initiated early.

Prescription medications for hair loss work through different mechanisms. Finasteride and dutasteride reduce DHT levels systemically. Minoxidil, available in both topical and oral formulations, acts as a vasodilator that prolongs the growth phase of hair follicles. All treatment decisions should be made by a qualified, independent doctor based on thorough clinical assessment.

Tratamente disponibile

The following medications are available for hair loss treatment through EU-registered doctors. This comparison is provided for informational purposes only. A doctor will assess which medication, if any, is appropriate for your individual situation.

MedicationActive IngredientFormPrimary UseEMA-Approved Indication
FinasterideFinasterideOral tabletMale pattern hair lossAndrogenetic alopecia in men (1 mg)
MinoxidilMinoxidilTopical solution / foamMale and female pattern hair lossAndrogenetic alopecia
DutasterideDutasterideOral capsuleMale pattern hair loss (off-label)EMA-approved for BPH; off-label for hair loss

Key distinctions:

  • Finasteride: The first-line oral treatment for male androgenetic alopecia. Clinical studies show it can halt progression and promote regrowth in the majority of men. Not appropriate for women of childbearing potential.
  • Minoxidil: Available in topical and, increasingly, low-dose oral formulations. Approved for use in both men and women. Effective as monotherapy or in combination with finasteride.
  • Dutasteride: Achieves higher DHT suppression than finasteride due to dual enzyme inhibition. Some clinical evidence supports greater efficacy, but it carries an off-label status for hair loss in most EU jurisdictions. A doctor will advise whether it is appropriate for you.

Cum puteți obține tratamente online

Prescrivia funcționează ca intermediar tehnologic: nu prescriem medicamente, nu angajăm medici și nu vindem medicamente. Platforma noastră conectează pacienții cu medici independenți înregistrați în UE, care pot efectua evaluări medicale online confidențiale.

Procesul este următorul:

  1. Completați un chestionar medical — Answer a structured set of medical questions covering the pattern and duration of your hair loss, family history, current medications, and relevant medical history. Photos may be requested to support the clinical assessment.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a hair loss medication is clinically appropriate, the doctor may issue a prescription. If it is not appropriate for your circumstances, the doctor will explain the reasoning.

  3. Prescripție și livrare — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The pharmacy dispenses the medication and arranges delivery directly to your address.

Important: Prescrivia nu garantează că o prescripție va fi emisă. Toate deciziile de prescriere sunt luate independent de medici calificați, pe baza circumstanțelor dumneavoastră clinice individuale. Prescription hair loss medications require a valid prescription from a licensed doctor.

Cum ne comparăm

Prin PrescriviaConsultație medicală în persoană
Disponibilitate24/7 online assessmentSubject to appointment availability
Timp de așteptareAssessment reviewed within hoursDays to weeks depending on location
Deplasare necesarăNoYes
Decizia de prescriereMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
CostTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Sudden or patchy hair loss, hair loss accompanied by scalp changes, or loss that may be secondary to an underlying medical condition (such as thyroid disease or nutritional deficiency) warrants in-person investigation before treatment. Prescrivia’s platform is designed for adults whose hair loss pattern is consistent with androgenetic alopecia suitable for remote assessment.

Surse

Informațiile medicale de pe această pagină se bazează pe următoarele surse:

  • European Medicines Agency (EMA). Propecia (finasteride) — Summary of Product Characteristics. Available at: ema.europa.eu
  • Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. JDDG. 2011;9(S6).
  • World Health Organization (WHO). Dermatological conditions — regional data. who.int

Acest conținut este revizuit periodic pentru a reflecta ghidurile clinice actualizate. Este furnizat exclusiv în scop informativ și nu constituie sfat medical. Consultați întotdeauna un profesionist medical calificat pentru sfaturi relevante pentru circumstanțele dumneavoastră individuale de sănătate.

Frequently asked questions

Pot obține Căderea părului online în Europa?
Puteți accesa acest medicament prin platforme intermediare online care vă conectează cu medici independenți înregistrați în UE. După completarea unui chestionar medical confidențial, un medic va evalua dacă medicamentul este adecvat clinic pentru dumneavoastră.
Care este diferența between finasteride and dutasteride?
Both medications work by inhibiting 5-alpha reductase enzymes that convert testosterone to dihydrotestosterone (DHT), the hormone primarily responsible for male pattern hair loss. Finasteride inhibits only the type II enzyme; dutasteride inhibits both type I and type II. Dutasteride achieves greater DHT suppression but is not EMA-approved for hair loss, meaning its use for this indication is off-label.
Can women use finasteride or minoxidil?
Finasteride is not generally prescribed for women who may become pregnant due to the risk of harm to a male foetus. Minoxidil, available in lower-concentration formulations, is used to treat female pattern hair loss and is EMA-approved for this indication. A doctor will assess what is appropriate based on your gender, age, and health profile.
Cât timp does it take to see results from hair loss medication?
Most clinical evidence indicates that meaningful results from finasteride or minoxidil require consistent use over at least 3 to 6 months. Hair regrowth, where it occurs, is typically gradual. Stopping medication usually results in reversal of benefit over time.
Există side effects associated with finasteride?
Finasteride is associated with sexual side effects in a minority of men, including reduced libido, erectile dysfunction, and ejaculation disorders. These effects are reversible on discontinuation in most cases. The prescribing doctor will discuss risks and benefits based on your individual health profile before issuing a prescription.
Prescrivia este doar o platformă intermediară. Nu furnizăm servicii medicale, nu prescriem tratamente și nu eliberăm medicamente. Toate deciziile medicale sunt luate de medici independenți înregistrați în UE. Toate medicamentele sunt eliberate de farmacii licențiate din UE. Această platformă facilitează legătura între pacienți și furnizorii de servicii medicale.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Sunteți gata să începeți?

Completați o evaluare de sănătate confidențială în aproximativ 3 minute.